The FDA plans to approve selected high-priority drug application submissions in 1 to 2 months rather than 10 to 12.

Research on the preferences of patients with AD, caregivers, and health care providers may be influenced by pharmaceutical company sponsorship.

Automated data review assists in identifying problematic opioid usage, outperforming manual methods in sensitivity and positive predictive value.

Mortality rates associated with calciphylaxis are lower than previously observed, with rates of 28.88% at 1-year and 29.92% at 2-years.

Rates of proven drug hypersensitivity reactions are comparable between children with and without inborn errors of immunity (IEI).

Patients who received oral tranexamic acid 500 mg daily for 3 months had reduced melasma severity and systemic inflammation markers.

Results of an autopsy-based study revealed that sudden cardiac death and multiorgan pathology may be more closely linked to SSc than previously thought.

Experienced epidemiologist Dr Fiona Havers resigned from the CDC due to her lack of confidence in the current leadership.

HealthDay News — Dozens of people in northeastern England have developed a rare and dangerous illness after receiving Botox injections, according to health officials in the U.K.

The LGBTQ+ specialized subprogram of the 988 National Suicide and Crisis Lifeline will no longer be available after July 17, 2025.

Ruxolitinib 0.75% cream and ruxolitinib 1.5% cream are effective and well-tolerated in children aged 2 to 11 years with atopic dermatitis.

The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.